The company anticipates Q4 revenue of $570M to $590M vs. $642M consensus and EPS of $0.68 to $0.75 vs. $0.91 consensus.
China was a major topic on the firm’s earnings call (39 mentions on the transcript), with execs highlighting some of the challenges in the region, but maintaining a confident tone for the future.
Shares of Nu Skin are down 14.66% to trade at their lowest level since early August.
Previously: Nu Skin EPS beats by $0.03, misses on revenue (Nov. 5)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.